Evidence map›Paper›PMID 28252203›Full record

ReviewBritish journal of pharmacology2017

Pathological overproduction: the bad side of adenosine.

Pier Andrea Borea, Stefania Gessi, Stefania Merighi, Fabrizio Vincenzi, Katia Varani

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Regulation of and challenges in targeting NADNature reviews. Molecular cell biology · 2024
    Review
  10. Article
  11. Review
  12. Nociceptive adenosine AInternational journal of oral science · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Adenosine Receptors as Potential Therapeutic Analgesic Targets.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pier Andrea BoreaDepartment of Medical Sciences, University of Ferrara, Ferrara, 44121, Italy.
Stefania GessiDepartment of Medical Sciences, University of Ferrara, Ferrara, 44121, Italy.
Stefania MerighiDepartment of Medical Sciences, University of Ferrara, Ferrara, 44121, Italy.
Fabrizio VincenziDepartment of Medical Sciences, University of Ferrara, Ferrara, 44121, Italy.
Katia VaraniDepartment of Medical Sciences, University of Ferrara, Ferrara, 44121, Italy.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine is an endogenous ubiquitous purine nucleoside, which is increased by hypoxia, ischaemia and tissue damage and mediates a number of physiopathological effects by interacting with four GPCRs, identified as A

Indexed as

AdenosineAnimalsHumansNeurodegenerative DiseasesAdenosine

Identifiers

PMID28252203
PMCPMC6398520
OpenAlexW2591914678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.